AMBANI ORGOCHEM LIMITEDAMBANIORGOCorporate

Latest results: Sep 2026 14 quarters of data

—

MCap —

Live price not available

AMBANI ORGOCHEM LIMITED — Stock analysis & AI research AMBANI ORGOCHEM LIMITED — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹171 Cr

Sales · Sep 2026

+54.3% YoY

₹11 Cr

Operating Profit · Sep 2026

+41.5% YoY

6.6%

OPM % · Sep 2026

-8.3% YoY

₹3 Cr

Net Profit · Sep 2026

₹4.02

EPS · Sep 2026

+1508.0% YoY

📝 AMBANI ORGOCHEM LIMITED — results explained

Quarter ended September 2026 (Q2 FY27)

AMBANI ORGOCHEM LIMITED reported revenue of ₹171 crore for the quarter ended September 2026 (Q2 FY27), up 54.3% from ₹111 crore in the same quarter last year.

Net profit stood at ₹3 crore. Earnings per share (EPS) came in at ₹4.02.

Operating profit stood at ₹11 crore — an operating margin (OPM) of 6.6%, compared with 7.2% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹304 crore with a net profit of ₹4 crore.

Shareholding pattern

As of Mar 2026, promoters held 61.25%, public shareholders 38.75% of AMBANI ORGOCHEM LIMITED.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

N/A

Current Price ?

N/A

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹304 Cr

OPM ?

6.4%

Profit after tax (TTM) ?

₹4 Cr

EPS (TTM) ?

₹4.92

ROCE ?

11.0%

ROE ?

7.1%

ROA ?

1.7%

Growth

Sales — latest qtr ?

₹171 Cr

PAT — latest qtr ?

₹3 Cr

YoY qtr sales growth ?

54.3%

YoY qtr profit growth ?

N/A

Sales growth (3y) ?

23%

Sales growth (5y) ?

23%

Profit growth (3y) ?

-13%

Profit growth (5y) ?

-4%

Financial Health

Debt ?

₹78 Cr

Debt to Equity ?

1.24

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

61.25%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

N/A

Return 6 months ?

N/A

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Sep bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026	Sep 2026	YoY %	QoQ %
Sales	36	26	61	67	59	67	66	62	74	82	112	111	133	171	+54.3%	—
Operating Profit	3	2	4	3	4	4	5	5	0	4	6	8	8	11	+41.5%	—
Other Income	0	0	0	0	0	0	0	0	5	0	0	0	0	—	—	—
Interest	1	2	1	1	2	2	2	3	4	4	3	5	4	5	+5.5%	—
Depreciation	0	0	1	1	1	1	1	1	1	1	2	2	2	2	+6.7%	—
Profit Before Tax	1	0	2	1	2	1	2	0	0	-1	2	1	3	4	+290.8%	—
Net Profit	1	0	1	1	1	1	1	0	3	-2	1	0	1	3	—	—
EPS	1.59	0.71	2.64	1.46	1.97	1.35	1.73	0.16	4.15	-2.52	1.21	0.25	1.49	4.02	+1508.0%	—
OPM %	8.3%	7.7%	6.6%	4.5%	6.8%	6.0%	7.6%	8.1%	0.0%	4.9%	5.4%	7.2%	6.0%	6.6%	-8.3%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 5 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026	% Chg
Equity Capital	6	7	8	12	9	-25.7%
Reserves	26	39	44	44	54	+23.0%
Borrowings	52	61	60	72	78	+8.5%
Other Liabilities	54	68	97	96	124	+28.8%
Total Liabilities	137	176	208	223	265	+18.7%
Fixed Assets	21	59	77	89	95	+7.1%
CWIP	47	8	7	0	—	—
Investments	0	0	0	0	0	—
Other Assets	69	109	124	134	169	+26.4%
Total Assets	137	176	208	223	265	+18.7%

📦 Working Capital (latest 1 periods)

Metric	Sep 2026	% Chg
Inventories	52	—
Trade Receivables	70	—
Trade Payables	108	—

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	16	-12	11	0	-100.0%
Cash from Investing Activity	-38	-1	2	-8	-500.0%
Cash from Financing Activity	17	14	-3	8	+366.7%
Net Cash Flow	-5	1	10	-1	-110.0%
Free Cash Flow	-22	-13	-9	-9	+0.0%
CFO/OP	204%	-262%	117%	1%	-99.1%

💧 Half-year Cash Flow (latest 1 periods)

Metric	Sep 2026	% Chg
Cash from Operating Activity	2	—
Cash from Investing Activity	-9	—
Cash from Financing Activity	5	—
Net Cash Flow	-2	—

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	78	72	80	75	-6.2%
Inventory Days	77	100	103	89	-13.6%
Days Payable	142	194	213	176	-17.4%
Cash Conversion Cycle	13	-22	-29	-12	+58.6%
Working Capital Days	-14	18	-29	-20	+31.0%
ROCE %	9%	2%	7%	11%	+57.1%

👥 Shareholding (latest 4 periods)

Metric	Nov 2024	Mar 2025	Sep 2025	Mar 2026	% Chg
Promoters	61.25%	61.25%	61.25%	61.25%	+0.0%
Public	38.75%	38.75%	38.75%	38.75%	+0.0%
No. of Shareholders	293	281	280	280	+0.0%

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.

❓ Frequently asked questions

What was AMBANI ORGOCHEM LIMITED's revenue in Q2 FY27?